Почетна › Рабидомиосарком › Kalifornija
Kliničke studije za Рабидомиосарком u državi Kalifornija
7 studija za Рабидомиосарком traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Zvanični tekst studije (na engleskom)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Lucile Packard Children's Hospital at Stanford, Palo Alto
- UCSF Benioff Children's Hospital, San Francisco
Тражи се учесникФаза 1
24 Months – 18 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06441331PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Cedars-Sinai Medical Center, Los Angeles
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст од 1 до 30 · Оба пола · Ажурирано 6. 10. 2026. · NCT06721689A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- и још 4
Тражи се учесникФаза 3
До 50 година · Оба пола · Ажурирано 25. 8. 2026. · NCT07466316Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 31. 7. 2026. · NCT07628634Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Stanford University, Palo Alto
Тражи се учесникФаза 2
До 22 година · Оба пола · Ажурирано 15. 6. 2026. · NCT06023641Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 19. 5. 2026. · NCT04901702Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.